يعرض 61 - 66 نتائج من 66 نتيجة بحث عن '"Giulino-Roth, Lisa"', وقت الاستعلام: 0.84s تنقيح النتائج
  1. 61
    دورية
    Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) after Treatment with Nivolumab for Relapsed/Refractory Hodgkin Lymphoma

    المؤلفون: Armand, Philippe, Zinzani, Pier Luigi, Collins, Graham P., Cohen, Jonathon B., Halwani, Ahmad S., Carlo-Stella, Carmelo, Millenson, Michael M., Provencio, Mariano, Domingo Domenech, Eva, Giulino Roth, Lisa, Castagna, Luca, Kato, Kazunobu, Popa McKiver, Mihaela, Sumbul, Anne, Zhu, Lili, Santoro, Armando

    المصدر: Blood; December 2016, Vol. 128 Issue: 22 p3502-3502, 1p

    النص الكامل

    أضف إلى المفضلة
  2. 62
    دورية
    Long-Term Follow up of Pediatric Patients with Hodgkin Lymphoma Treated with High Dose Therapy and Autologous Stem Cell Transplantation

    المؤلفون: Giulino Roth, Lisa, O'Donohue MD, Tara, Trippett, Tanya, Klein, Elizabeth, Kernan, Nancy A., Kobos, Rachel, Prockop, Susan, Scaradavou, Andromachi, Shukla, Neerav, Steinherz, Peter G, Moskowitz, Alison J, Moskowitz, Craig H., Boulad, Farid

    المصدر: Blood; December 2015, Vol. 126 Issue: 23 p2000-2000, 1p

    النص الكامل

    أضف إلى المفضلة
  3. 63
    دورية
    Targeting the Hsp90 Oncoproteome in Burkitt Lymphoma

    المؤلفون: Giulino Roth, Lisa, van Besien, Herman, Rodina, Anna, Taldone, Tony, Erdjument-Bromage, Hediye, Barth, Matthew J., Chiosis, Gabriela, Cesarman, Ethel

    المصدر: Blood; December 2015, Vol. 126 Issue: 23 p592-592, 1p

    النص الكامل

    أضف إلى المفضلة
  4. 64
    دورية
    Ibrutinib Significantly Prolonged Survival in a Human Burkitt Lymphoma (BL) Xenograft NSG Mouse Model: Ibrutinib May be a Potential Adjuvant Agent in the Treatment of BL

    المؤلفون: Lee, Sanghoon, Yin, Changhong, Ayello, Janet, Morris, Erin, O'Connell, Timmy, Harrison, Lauren, van de Ven, Carmella, Barth, Matthew J., Miles, Rodney R., Galardy, Paul J., Goldman, Stanton, Lim, Megan S, Hermiston, Michelle L., McAllister-Lucas, Linda, Giulino-Roth, Lisa, Perkins, Sherrie L., Cairo, Mitchell S.

    المصدر: Blood; December 2015, Vol. 126 Issue: 23 p5117-5117, 1p

    النص الكامل

    أضف إلى المفضلة
  5. 65
    دورية
    Ibrutinib Alone and in Combination with Dexamethasone and Carfilzomib Significantly Inhibits Cell Proliferation in Primary Mediastinal B-Cell Lymphoma (PMBL): Ibrutinib May be a Future Targeted Agent in Combination Therapy in Patients with PMBL

    المؤلفون: Lee, Sanghoon, Yin, Changhong, Ayello, Janet, Morris, Erin, Harrison, Lauren, van de Ven, Carmella, Barth, Matthew J., Miles, Rodney R., Galardy, Paul J., Goldman, Stanton, Lim, Megan S, Hermiston, Michelle L., McAllister-Lucas, Linda, Giulino-Roth, Lisa, Perkins, Sherrie L., Cairo, Mitchell S.

    المصدر: Blood; December 2015, Vol. 126 Issue: 23 p4852-4852, 1p

    النص الكامل

    أضف إلى المفضلة
  6. 66
    دورية أكاديمية
    293 - A Pilot Study of a Sequential Regimen of Intensive Chemotherapy (Bendamustine-Bridge) Followed by Autologous or Allogeneic Transplantation for Refractory Lymphomas.

    المؤلفون: Shore, Tsiporah B.1, Jhanwar, Yuliya2, Baldo, Maria3, Cuvilly, Edwidge3, Furman, Richard3, Gergis, Usama1, Greenberg, June3, Guarneri, Danielle3, Hsu, Jing-Mei1, Leonard, John3, Mark, Tomer M.3, Maignan, Kathleen3, Martin, Peter3, Mayer, Sebastian1, Niesvizky, Ruben3, Opong, Adomah3, Pearse, Roger3, Phillips, Adrienne1, Rossi, Adriana3, Giulino-Roth, Lisa3

    المصدر: Biology of Blood & Marrow Transplantation. Mar2017 Supplement, Vol. 23, pS272-S272. 1p.

    مصطلحات موضوعية: *LYMPHOMA treatment, *CANCER chemotherapy, *DISEASE relapse, *SALVAGE therapy, *PILOT projects

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث